CompanyQNTMNasdaqToronto

Quantum Biopharma Ltd.

Quantum Biopharma develops drug candidates for neurodegenerative, metabolic, and alcohol misuse disorders.

SEC EDGAR ClinicalTrials.gov unbuzzd.com

6-KSep 24Latest SEC filing, period to Sep 24

Sep 24Latest story

September 2026

Unbuzzd Wellness names Michael Zapolin as CEO ahead of planned stock listing

Sep 24PeopleQuantum Biopharma Ltd.

August 2026

Quantum BioPharma gets FDA nod to start Lucid-MS Phase 2 trial in progressive MS

Aug 14Regulatory decisionQuantum Biopharma Ltd.

Quantum BioPharma gets FDA clearance to start Lucid-MS Phase 2 in progressive MS

Aug 10Clinical readoutQuantum Biopharma Ltd.